ACE2 and chronic obstructive pulmonary disease: We and others have shown in human tissue (smokers, chronic obstructive pulmonary disease, COPD) that the expression of ACE2 was increased in type-2 pneumocytes, alveolar macrophages, and small airway epithelium in comparison with healthy control tissue [22,23,24,25].